WHO ICTRP trial
Effects of esomeprazole on symptoms indicative of gastroesophageal reflux…
JPRN-jRCT1091220218 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT1091220218 |
|---|---|
| Public title | Effects of esomeprazole on symptoms indicative of gastroesophageal reflux disease observed in patients taking non-steroidal anti-inflammatory drugs (NSAIDs) |
| Scientific title | Effects of esomeprazole on symptoms indicative of gastroesophageal reflux disease observed in patients taking non-steroidal anti-inflammatory drugs (NSAIDs) - Esomeprazole against GERD symptoms induced by NSAIDs |
| Primary sponsor | Department of Orthopedic surgery, graduate school of medicine, Chiba University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Japan |
| Conditions | Patients who scored more than 8 on F scale questionnaire after taking NSAIDs more than 4 weeks are enrolled. |
| Interventions | Intervention type:DRUG Name of intervention:Oral administration esomeprazole on symptoms indicative of gastroesophageal reflux disease observed in patients taking non-steroidal anti-inflammatory drugs Dose form / Japanese Medical Device… |
| Registration date | Jul 21, 2015 |
| Target size | 100 |
| Secondary IDs | Nill Known;JMA-IIA00218 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: